BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36458320)

  • 1. Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
    Kars TU; Yorgancı ZF; Yaşkıran O; Tekinalp A; Demircioğlu S
    J Oncol Pharm Pract; 2023 Jun; 29(4):1011-1014. PubMed ID: 36458320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Rituximab-Induced Acute Thrombocytopenia in a Patient with Splenic Marginal Zone Lymphoma and Chronic Hepatitis C Virus Infection.
    Qureini A; Asif S; Harry S; Madhusudhana S
    Am J Case Rep; 2019 Sep; 20():1394-1397. PubMed ID: 31541071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab-induced acute thrombocytopenia in patients with splenomegaly B Cell lymphoma: an underdiagnosed but severe complication.
    Jiang Y; Song J; Wang N; Yuan D; Feng L; Qu H; Fan J
    Cancer Biol Ther; 2020 Nov; 21(11):1060-1066. PubMed ID: 33121338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
    Robinson AC; Nachar VR
    J Oncol Pharm Pract; 2020 Jul; 26(5):1248-1253. PubMed ID: 31766968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-induced Acute Thrombocytopenia in a Patient with Follicular Lymphoma: A Case Report and Review of the Literature.
    Omura Y; Shimazu H; Takahashi T
    Intern Med; 2018 Apr; 57(8):1151-1154. PubMed ID: 29269668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma: a case report and literature review].
    Huang AJ; Ni X; Fu WJ; Zhang Y; Tang GS; Wang JM
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):338-342. PubMed ID: 33979980
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma.
    Sadashiv SK; Rao R; Fazal S; Lister J
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):602-5. PubMed ID: 23870855
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-induced acute thrombocytopenia: a case report and review of the literature.
    Yi JH; Kim SJ; Ahn HK; Lee SJ; Chang MH; Kim WS
    Med Oncol; 2009; 26(1):45-8. PubMed ID: 18543133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
    Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
    J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rituximab-induced acute thrombocytopenia in a patient with chronic lymphocytic leukemia].
    Bobot M; Benzaquen M; Rouby F; Lebowitz D; Serratrice J; Durand JM
    Rev Med Interne; 2017 May; 38(5):344-346. PubMed ID: 27639907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma.
    Wilop S; Galm O; Dada R; Osieka R; Jost E
    Leuk Lymphoma; 2008 Nov; 49(11):2116-24. PubMed ID: 19021054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma.
    Ureshino H; Nishioka A; Kojima K; Suzuki M; Kizuka H; Sano H; Shindo T; Kubota Y; Ando T; Kimura S
    Intern Med; 2016; 55(15):2061-4. PubMed ID: 27477415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report.
    Yudhishdran J; Sivakumar J; Navinan MR; Bandapatti S
    J Med Case Rep; 2021 Jul; 15(1):339. PubMed ID: 34233732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.
    Ratanatharathorn V; Carson E; Reynolds C; Ayash LJ; Levine J; Yanik G; Silver SM; Ferrara JL; Uberti JP
    Ann Intern Med; 2000 Aug; 133(4):275-9. PubMed ID: 10929168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature.
    Yassa G; Shakir AR; Jagarlamudi K; Yassa AE
    J Oncol Pharm Pract; 2021 Jan; 27(1):253-257. PubMed ID: 32611269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8).
    Winkler U; Jensen M; Manzke O; Schulz H; Diehl V; Engert A
    Blood; 1999 Oct; 94(7):2217-24. PubMed ID: 10498591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
    Tsimberidou AM; Catovsky D; Schlette E; O'Brien S; Wierda WG; Kantarjian H; Garcia-Manero G; Wen S; Do KA; Lerner S; Keating MJ
    Cancer; 2006 Jul; 107(1):125-35. PubMed ID: 16700034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Kalpadakis C; Pangalis GA; Dimopoulou MN; Vassilakopoulos TP; Kyrtsonis MC; Korkolopoulou P; Kontopidou FN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Tsaftaridis P; Plata E; Angelopoulou MK
    Hematol Oncol; 2007 Sep; 25(3):127-31. PubMed ID: 17514771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.